PULMATRIX, INC. Current Assets
PULMATRIX, INC. (PULM) had Current Assets of $3.24 million as of 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-17
- 2026-06-30: Assets, Current $3.24M.
- 2026-03-31: Assets, Current $4.49M.
- 2025-12-31: Assets, Current $4.13M.
- 2025-09-30: Assets, Current $4.97M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.24M S-4/A · filed 2026-09-17 | |
| 2026-03-31 | $4.49M S-4/A · filed 2026-08-03 | |
| 2025-12-31 | $4.13M S-4/A · filed 2026-09-17 | |
| 2025-09-30 | $4.97M 10-Q · filed 2025-10-16 | |
| 2025-06-30 | $6.14M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $8.04M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $9.92M S-4/A · filed 2026-09-17 | |
| 2024-09-30 | $11.45M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $15.64M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $17.58M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $20.84M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $23.23M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $27.38M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $32.80M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $38.15M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $43.23M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $45.84M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $50.61M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $54.78M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $54.44M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $60.47M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $64.49M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $32.46M 10-K · filed 2022-03-29 | $32.54M 10-K · filed 2021-03-23 |
| 2020-09-30 | $37.12M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $29.06M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $26.25M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $31.42M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $28.84M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $32.93M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $3.38M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.28M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $4.72M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $8.96M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $2.05M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $4.25M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $7.55M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $11.73M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $10.95M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $4.76M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $8.34M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $11.80M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $15.76M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $20.46M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $23.36M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $26.02M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $10.52M 10-K · filed 2015-06-10 | |
| 2014-12-31 | $831.00K 10-K · filed 2016-03-10 | $11.77M 10-Q · filed 2015-02-13 |
| 2014-09-30 | $13.17M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $14.64M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $15.57M 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |